An Israeli pharmaceutical company is developing what it hopes will be the world's first insulin pill to replace daily injections for diabetics.
If clinical trials prove successful, the company believes the tablet will transform the lives of diabetics and radically reduce the cost of providing treatment.
Half a dozen volunteers are taking part in trials at a hospital in northern Israel.
One volunteer said relying on injections can be burdensome.
"I take three or four shots a day, and with this product you just need to swallow a pill and it takes your blood sugar down,” said Type I Diabetic Yaniv Cohen. “I think one of the reasons I came here, I wanted to try it, instead of taking the shots."
The company needs to conduct more trials before the drug is licensed for sale, so the capsule could still be years away from commercialization.